Dobrovolsky V N, Casciano D A, Heflich R H
Division of Genetic Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079, USA.
Environ Mol Mutagen. 1996;28(4):483-9. doi: 10.1002/(SICI)1098-2280(1996)28:4<483::AID-EM26>3.0.CO;2-A.
A tk+/- mouse embryonic stem (ES) cell line, designated 1G2, has been created in which one allele of the thymidine kinase (tk) gene was inactivated by targeted homologous recombination. This line is an analog of the mouse lymphoma tk+/- L5178Y cell line, which is used widely to assess the mutagenicity of chemical agents. Treatment of 1G2 cells with the alkylating agent N-ethyl-N-nitrosourea (ENU) resulted in a dose-related increase in trifluorothymidine-resistant colonies. Mutant frequencies of 152 and 296 per 10(6) cells were determined for 0.1 and 0.3 mg/ml doses of ENU, compared with a spontaneous mutant frequency of 15 per 10(6) cells. The data indicate that tk+/- 1G2 ES cells may be useful for the creation of a transgenic mouse model for assessing in vivo mutation using an endogenous autosomal gene.
已创建了一个tk+/-小鼠胚胎干细胞(ES)系,命名为1G2,其中胸苷激酶(tk)基因的一个等位基因通过靶向同源重组被灭活。该细胞系类似于小鼠淋巴瘤tk+/- L5178Y细胞系,后者被广泛用于评估化学试剂的致突变性。用烷基化剂N-乙基-N-亚硝基脲(ENU)处理1G2细胞导致对三氟胸苷耐药菌落呈剂量相关增加。对于0.1和0.3mg/ml剂量的ENU,测定的突变频率分别为每10(6)个细胞152和296个,而自发突变频率为每10(6)个细胞15个。数据表明,tk+/- 1G2 ES细胞可能有助于创建一个使用内源性常染色体基因评估体内突变的转基因小鼠模型。